Triglyceride-rich lipoproteins may be responsible for the lipid accumulation in macrophages that can occur in hypertriglyceridemia. Chylomicrons and very low density lipoproteins (VLDL, total and with flotation constant [S f ] 100-400) from fasting hypertriglyceridemic subjects induced a massive accumulation of oil red O-positive inclusions in unstimulated peritoneal macrophages. Cell viability was not affected. The predominant lipid that accumulated in cells exposed to hypertriglyceridemic VLDL was triglyceride. Hypertriglyceridemic VLDL stimulated the incorporation of [ 14 C]oleate into cellular triglyceride up to ninefold in 16 h, but not into cholesteryl esters. Mass increase in cellular triglyceride was 38-fold. The stimulation of cellular triglyceride formation was dependent on time, temperature, and concentration of hypertriglyceridemic VLDL. By contrast, VLDL, low density, and high density lipoproteins from fasting normolipemic subjects had no significant effect on oleate incorporation into neutral lipids or on visible lipid accumulation.
A B S T R A C T Triglyceride-rich lipoproteins may be responsible for the lipid accumulation in macrophages that can occur in hypertriglyceridemia. Chylomicrons and very low density lipoproteins (VLDL, total and with flotation constant [Sf] 100-400) from fasting hypertriglyceridemic subjects induced a massive accumulation of oil red 0-positive inclusions in unstimulated peritoneal macrophages. Cell viability was not affected. The predominant lipid that accumulated in cells exposed to hypertriglyceridemic VLDL was triglyceride. Hypertriglyceridemic VLDL stimulated the incorporation of [14C]oleate into cellular triglyceride up to ninefold in 16 h, but not into cholesteryl esters. Mass increase in cellular triglyceride was 38-fold. The stimulation of cellular triglyceride formation was dependent on time, temperature, and concentration of hypertriglyceridemic VLDL. By contrast, VLDL, low density, and high density lipoproteins from fasting normolipemic subjects had no significant effect on oleate incorporation into neutral lipids or on visible lipid accumulation.
1251-Hypertriglyceridemic VLDL (Sf 100-400) were degraded by macrophages in a dose-dependent manner, with 50 and 100% saturation observed at 3 and 24 Ag protein/ml (2.5 and 20 nM), respectively. Hypertriglyceridemic VLDL inhibited the internalization and degradation of '251-hypertriglyceridemic VLDL (4 nM) by 50% at 3 nM. Cholesteryl ester-rich VLDL from cholesterol-fed rabbits gave 50% inhibition at 5 nM. Low density lipoproteins (LDL) inhibited INTRODUCTION Some forms of hypertriglyceridemia are associated with premature atherosclerosis and with the accumulation of lipid-filled macrophages throughout the body (1) . Macrophages have been implicated in atherogenesis; some of the foam cells found in arterial plaques may be derived from blood-born monocytemacrophages (2, 3) . Elevated levels of functionally abnormal triglyceride-rich lipoproteins may contribute to these pathologic conditions. We have found that very low density lipoproteins (VLDL)' from hypertriglyceridemic but not normal subjects suppress the activity of 3-hydroxy-3-methylglutaryl-CoA reductase in cultured human fibroblasts and endothelial cells via the low density lipoprotein (LDL) receptor pathway (4) (5) (6) . Moreover, low levels of the hypertriglyceridemic VLDL, but not normal VLDL, are toxic to cultured vascular endothelial cells; this, potentially, is an atherogenic consequence of abnormal receptor-me-diated uptake (6) . Macrophages, however, including those from mouse peritoneal cavity, have few classical LDL cell surface receptors (7) . Peritoneal macrophages take up only small amounts of normal LDL, but internalize large quantities of LDL that have been modified chemically so that their net charge is more negative, as by acetylation (7, 8) , or LDL that is complexed to high molecular mass (500,000 daltons) dextran sulfate (9) . In addition to recognizing the chemically modified or complexed LDL, mouse peritoneal macrophages have a cell-surface receptor that appears to be specific for cholesteryl ester-rich (CER) f3-VLDL, a lipoprotein that accumulates in the blood of cholesterol-fed animals (10) . After uptake by any of these receptor-mediated pathways, the CER lipoproteins are hydrolyzed in the lysosomes. The released cholesterol is reesterified in the cytoplasm where it accumulates as lipid droplets. These droplets can be visualized after staining with the neutral lipid stain oil red 0 or by their birefringence under polarized light. Human monocyte-derived macrophages possess both the scavenger pathway, which recognizes acetylated or malondialdehyde-treated LDL, as well as the classical LDL receptor pathway (11) (12) (13) .
We now report that VLDL from the plasma of hypertriglyceridemic subjects, with no chemical modi 
METHODS
Animals. 6-8-wk-old Balb/c, C3H/HeJ, and C3HeB/FeJ mice of both sexes were purchased from Jackson Laboratories, Bar Harbor, ME. Mice were housed in cages equipped with barrier filters and fed standard laboratory chow and water ad lib.
Preparation and culture of macrophage monolayers. Detailed descriptions for isolation of mouse peritoneal leukocytes and preparation of adherent cell (macrophage) monolayers have been published previously (14, 15) . Cells were collected from normal, unstimulated mice by repeatedly injecting 3 ml of tissue culture medium (TCM) intraperitoneally and aspirating the fluid contents with a syringe. The TCM consisted of Dulbecco's modified Eagle's medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) supplemented with 5% (vol/vol) human lipoprotein-deficient serum, d > 1.21 (LPDS), 2 mM glutamine, 36 mM NaHCO3, 100 U/ml potassium penicillin G, and 100 gg/ml streptomycin sulfate. Harvests from 10 to 24 mice were pooled, pelleted by centrifugation (400 g for 10 min) at 4°C, washed in Hanks' balanced salt solution or TCM and resuspended in TCM at 2 X 106 cells/ml. 1 1 h at 37°C in a humidified chamber containing an atmosphere of 83% N2, 10% CO2, and 7% 02. After gentle agitation, nonadherent leukocytes were removed by aspirating the supernatant with a sterile Pasteur pipette and by washing monolayers two times with 1-ml portions of TCM. To initiate each experiment, 1 ml TCM and serum lipoproteins were added to macrophage monolayers and incubated under conditions described above for the designated time periods.
Characterization of lipoprotein-induced cytoplasmic inclusions. Macrophage monolayers were prepared as described (15) by overlaying 22 X 22-mm sterile glass cover slips with 0.3 ml of the peritoneal leukocyte suspension. Following 1-h incubation at 37°C, cover slips were rinsed in a beaker containing TCM and placed in a 35-mm culture dish containing 1 ml TCM. Lipoproteins were added and cultures were incubated under standard conditions for varying lengths of time. At termination, cover slips were removed and thoroughly washed by three successive transfers to culture dishes containing 1 ml phosphate-buffered saline with 2% bovine serum albumin. Cover slips were then fixed in 60% isopropyl alcohol, stained with oil red 0, counterstained with Harris' hematoxylin, and mounted, face-down, on glass microscope slides using prewarmed (45°C) glycerin jelly. Slide preparations were examined by light microscopy at X1,000 magnification; the number of oil red 0-staining inclusions per cell in 100 randomly observed cells were tabulated with each slide.
Conditions for the massive accumulation of cholesteryl esters in acetyl LDL-treated macrophages were followed in order to analyze hypertriglyceridemic VLDL-induced cytoplasmic lipids by polarized light microscopy (8) . Macro Uptake of '"I-VLDL was measured as the cell-associated radioactivity after extensive washing with chilled albumincontaining buffer (30) . The amount of noniodide, nonlipid, trichloroacetic acid-soluble radioactivity in the medium was used as a measure of iodinated lipoprotein degradation (30) ; these values were corrected for nonspecific degradation by subtracting the amount degraded in control dishes that contained no cells. For mass analysis of cellular triglyceride, cholesterol, and cholesteryl ester, the cells of 24 mice were pooled and seeded in nine 60-mm dishes. After nonadherent cells were removed, three dishes of macrophages were incubated in the absence of lipoproteins (group A); three dishes with acetyl-LDL, 45 pg protein/ml (group B); and three dishes (group C) with hypertriglyceridemic VLDL1 (subject J.P., type V pattern, 29 pg protein, 218 pg triglyceride/ml). After incubation at 37°C for 22 h the dishes were chilled on ice. To ensure that the increase in cell-associated triglyceride in group C were not due to surface bound VLDL rather than intracellular triglyceride, the equivalent amount of hypertriglyceridemic VLDL1 previously fed to group C cells was added to each of the chilled control dishes. The medium from each dish was then aspirated, the cells washed five times with ice-cold buffered saline containing 0.2% bovine serum albumin (fatty acid free) and two times with cold buffered saline. The cells were harvested and total lipids were extracted with chloroform/methanol (2:1). The total lipid'-extracts from dishes in each group were combined, evaporated, and dissolved in 10 pl of isopropanol before separation by thin-layer chromatography on rods covered with a thin layer of scintered silicic acid (Chromarods, latron Laboratories, Inc., Tokyo, Japan). The lipids were quantified by means of a flame ionization detector (latron TH-10 analyzer, latron Laboratories, Inc.) (31) . (Table I ). This relatively simple visual method represents a rapid, semiquantitative way of comparing the abilities of various lipoproteins to induce lipid accumulation in the macrophages. Chylomicrons isolated from the plasma of a patient with type V hyperlipoproteinemia also induced lipid accumulation in macrophages (Table I) .
The experiment illustrated in Fig. 2 VLDL are heterogeneous with respect to size, density, and composition. A potential explanation for the differences in effects of normal and hypertriglyceridemic VLDL on triglyceride accumulation by macrophages is that the abnormal total VLDL contain more large, triglyceride-rich particles than normal VLDL. We therefore isolated more homogeneous subclasses by a cumulative flotation procedure devised by Lindgren and associates (17) and tested these for their effects on visible lipid accumulation. As we have previously reported (5) , the composition of VLDL subclasses from normal subjects are similar to the comparable subclasses from hypertriglyceridemic subjects with hyperlipoproteinemia types IV and V: the percent weight of the major components of Sf 100-400 normal VLDL (hypertriglyceridemic type IV VLDL) were 5.9±0.7 (5.0±1.0) protein; 18.5±1.9 (15.5±1.4) phospholipid; 5.9±1.4 (5.8±1.1)cholesterol; 6.1±1.6 (8.4±1.9) cholesteryl ester; and 63.6±2.6 (65.4±3.4) triglyceride (mean±SD; n = 5, normal; n = 4, hypertriglyceridemic subjects). There were no apparent differences in total apoB, apoE, or C peptide content as judged by polyacrylamide gel electrophoresis (5).
Thus, normal and hypertriglyceridemic VLDL subclasses at equal protein contents are equivalent both in triglyceride contents and in particle numbers. The largest VLDL subclass (Sf 100-400, VLDLI) from hypertriglyceridemic subjects produced the greatest increase in the percentage of cells with increased visible lipid content and could account for most of the accumulation noted in cells exposed to the unfractionated VLDL (Table II) . It is noteworthy that the pres- A plot of the percentage of cells containing five or more lipid droplets per cell against the concentration of hypertriglyceridemic VLDL1 to which the cells had been exposed was distinctly curvilinear after brief (3-4-h) incubations, with saturation at 320 pg triglyceride/ml. Saturability suggests that the visible lipid accumulation is a result of interaction of the hypertriglyceridemic VLDL with a limited number of cell sites rather than due to a nonspecific pinocytotic mechanism.
Thus, unstimulated macrophages assume the morphology of foam cells when incubated with hypertriglyceridemic VLDL but not when incubated with normal LDL, HDL, or VLDL, even at normal VLDL triglyceride levels of 650 pg/ml, far above saturating levels for hypertriglyceridemic VLDL. The ability of total hypertriglyceridemic VLDL to induce lipid accumulation resides primarily in the largest subclass, VLDL1.
Macrophages accumulate triglyceride. The lipid that accumulates in macrophages exposed to acetyl LDL is cholesteryl ester and, as such, shows typical birefringence when observed by polarized light microscopy (8) . By comparison, cells exposed to hypertriglyceridemic VLDL become filled with oil red 0- (Fig. 3) . Oleate incorporation into cellular triglyceride induced by hypertriglyceridemic VLDL is linear for at least 4 h. This process increases in a dose-dependent, saturable manner (Fig. 4) (Fig. 6) .
We have also examined the uptake and degradation of iodinated hypertriglyceridemic VLDL, by macrophages to determine if uptake is facilitated by a specific receptor and is, therefore, saturable. Uptake and degradation occurred in a curvilinear, dose-dependent manner, with 50 and 100% saturation at 3 and 24 ,ug protein/ml (20 and 160 ,ug triglyceride/ml), respectively (Fig. 7) . When based on particles of VLDLI/ml niedium, these values are equivalent to 2.5 and 20
pmol VLDLI/ml (nM).
Competition studies showed that hypertriglyceridemic VLDL, were highly effective in inhibiting the internalization and degradation of '251-hypertriglycer- 4 Concentration-dependent incorporation of oleate into triglyceride in macrophages exposed to hypertriglyceridemic VLDL. Cells were isolated and grown in 35-mm tissue culture dishes (Methods). After the nonadherent cells were removed, each dish of macrophages was incubated at 370 for 3.5 h in 1 ml of TCM plus 0.02 ml of 10 mM '4C]oleate/albumin and 0.2 ml of saline (four dishes) or hypertriglyceridemic VLDL (Sf 100-400, subject H.W., type IV profile) at the indicated final concentrations. Each point represents the average of values of two dishes, except the control value which is the average of four dishes. The protein content averaged 22 idemic VLDLI, with 50% inhibition at 3 nM (Fig. 8) . CER-VLDL from cholesterol-fed rabbits were nearly as effective, giving 50% inhibition at a level of 5 pmol/ ml (5 nM). LDL were less effective, with 10% inhibition at 5 nM and 40% inhibition at 47 nM. Acetyl LDL did not compete at 130 nM. These results indicate that hypertriglyceridemic VLDL uptake and degradation are mediated via specific receptors that recognize CER-VLDL but are distinct from the receptors for acetyl LDL. To determine whether or not lysosomal hydrolysis of the hypertriglyceridemic VLDL is required for the stimulation of oleate incorporation, the cells were incubated at 37°C for 16 h in the presence and absence of 20,M chloroquine with and without hypertriglyceridemic VLDL or acetyl LDL. In the absence of added lipoprotein, the basal incorporation of oleate into cellular triglyceride was 53 nmol/mg (57 in the presence of chloroquine). Hypertriglyceridemic VLDL (7-9, 11, 12) , by abnormal lipoproteins induced by cholesterol feeding (10), or by prolonged (.4 d) incubation (13). Our results suggest a possible cellular mechanism for the relationship between hypertriglyceridemia and atherosclerosis (1, 34) . Pronounced triglyceride reesterification and accumulation were apparent after only 4-h incubation of macrophages with hypertriglyceridemic VLDL. These phenomena were not observed with VLDL obtained from fasting normolipemic subjects, even when incubated for 24 (Fig. 8) suggests that some uptake is mediated by receptors equivalent to the fibroblast B/E (LDL) receptor, which recognizes both hypertriglyceridemic VLDL and CER-VLDL (4, 5, 10, 18 ng/dish and SD was <5%. Hypertriglyceridemic (HTG) VLDL was run in each experiment and gave essentially identical competition curves (50% inhibition at 3 pmol HTG VLDLI/ml).
The distinctive features of VLDL from patients with type IV and type V hyperlipoproteinemia, which result in enhanced interactions with cells, have not yet been identified. We have found no consistent changes in major lipid or apoprotein components between the normal and the type IV or type V VLDL that could account for their differences in reactivity with the fibroblast LDL receptor and now with macrophages (4, 5) . The receptor recognition factors present in the hypertriglyceridemic VLDL probably are due to apoB or apoE or both, since rabbit CER-VLDL apoproteins are almost entirely apoB and apoE, with little or no apoC present. A configuration of apoB/E similar to that of ,B-VLDL on the surface of hypertriglyceridemic VLDL that is masked or lacking in normal VLDL may account for the cellular uptake of hypertriglyceridemic but not normal VLDL,; this would not necessarily be reflected by major compositional abnormalities.
Macrophages store the major lipid carried by the lipoproteins that they actively internalize. Thus, acetyl LDL and CER-VLDL produce cholesteryl ester reesterification and accumulation. By contrast, but in an analogous fashion, the triglyceride-rich hypertriglyceridemic VLDL induce triglyceride reesterifica-tion and storage. The moderate increase in cellular cholesterol mass after incubation with hypertriglyceridemic VLDL reflects the lower amounts of cholesterol relative to triglyceride present in these lipoproteins. Lysosomal hydrolysis of VLDL triglycerides would produce free fatty acids. Reesterification and storage of the fatty acids as nontoxic glycerides would protect the cells from toxic effects of free fatty acids. Indeed, even prolonged exposure to high levels of hypertriglyceridemic VLDL failed to reduce cell viability. The effect, however, was to produce cells with all the morphologic characteristics of foam cells.
Lipid-filled macrophages accumulate in hyperlipoproteinemia types I, III, and V, all of which are characterized in part by hypertriglyceridemia (1) . Normally, catabolism of triglycerides in large VLDL is mediated by lipoprotein lipase. In hypertriglyceridemia, however, the lipoprotein lipase pathway is overloaded, either because of an absolute or a relative deficiency (such as saturation) of the enzyme. Triglyceride-rich lipoproteins accumulate in the plasma and catabolism of these particles may be diverted through the macrophage pathway, resulting in foam cell accumulation. In eruptive xanthomas associated with hypertriglyceridemia, the predominant lipid found in macrophage-derived foam cells is triglyceride (35) . With lesion regression, the triglyceride is rapidly lost but cholesterol remains as the major lipid. Since some foam cells in atheromatous lesions may be derived from blood-born monocytes (2, 3), uptake of triglyceride-rich lipoproteins by monocyte-macrophages in vivo in hypertriglyceridemic subjects potentially could initiate a similar sequence of lipid accumulation and be a significant factor in the pathophysiology of atherosclerosis.
